Brandes Investment Partners LP trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 987,277 shares of the company's stock after selling 30,379 shares during the period. Cardinal Health makes up 1.3% of Brandes Investment Partners LP's portfolio, making the stock its 26th biggest position. Brandes Investment Partners LP owned 0.41% of Cardinal Health worth $116,765,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the company. Frazier Financial Advisors LLC boosted its stake in Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock valued at $28,000 after acquiring an additional 104 shares during the last quarter. Promus Capital LLC bought a new position in Cardinal Health during the 4th quarter valued at $30,000. AM Squared Ltd bought a new position in Cardinal Health during the 3rd quarter valued at $33,000. Kentucky Trust Co bought a new position in Cardinal Health during the 4th quarter valued at $41,000. Finally, HHM Wealth Advisors LLC boosted its stake in Cardinal Health by 57.6% during the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after acquiring an additional 144 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.
Cardinal Health Trading Up 0.5 %
Cardinal Health stock traded up $0.63 during midday trading on Wednesday, reaching $132.09. 1,364,395 shares of the stock traded hands, compared to its average volume of 1,967,222. The firm has a fifty day moving average price of $126.75 and a two-hundred day moving average price of $119.69. The firm has a market cap of $31.91 billion, a price-to-earnings ratio of 24.64, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $133.12.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.53%. Cardinal Health's dividend payout ratio (DPR) is 37.69%.
Wall Street Analyst Weigh In
A number of research analysts have commented on the stock. Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. JPMorgan Chase & Co. raised their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Morgan Stanley raised their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Wells Fargo & Company raised their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Finally, Bank of America upgraded shares of Cardinal Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, Cardinal Health currently has a consensus rating of "Moderate Buy" and an average target price of $139.36.
Get Our Latest Research Report on Cardinal Health
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
